Pletcher Brett A 4
4 · GILEAD SCIENCES, INC. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Pletcher Brett A
EVP, Gen Counsel & Corp Sec
Transactions
- Exercise/Conversion
Restricted Stock Unit
2022-03-10−2,593→ 20,431 total→ Common Stock (2,593 underlying) - Exercise/Conversion
Common Stock
2022-03-10+2,593→ 35,169 total - Exercise/Conversion
Common Stock
2022-03-10+3,130→ 38,299 total - Tax Payment
Common Stock
2022-03-10$57.92/sh−2,089$120,995→ 36,210 total - Sale
Common Stock
2022-03-11$58.24/sh−3,634$211,644→ 32,576 total - Exercise/Conversion
Restricted Stock Unit
2022-03-10−3,130→ 17,301 total→ Common Stock (3,130 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
- [F3]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.